8G1V
 
 | | Crystal Structure Matriptase (C731S) in Complex with Inhibitor MM1132-2 | | 分子名称: | CHLORIDE ION, GLYCEROL, N~2~-{[3-(acetamidomethyl)phenyl]acetyl}-N-[(2S)-1-(1,3-benzothiazol-2-yl)-5-carbamimidamido-1,1-dihydroxypentan-2-yl]-L-leucinamide, ... | | 著者 | Lovell, S, Kashipathy, M.M, Battaile, K.P, Janetka, J.W. | | 登録日 | 2023-02-03 | | 公開日 | 2024-07-10 | | 最終更新日 | 2024-08-14 | | 実験手法 | X-RAY DIFFRACTION (1.35 Å) | | 主引用文献 | Use of protease substrate specificity screening in the rational design of selective protease inhibitors with unnatural amino acids: Application to HGFA, matriptase, and hepsin.
Protein Sci., 33, 2024
|
|
8G1W
 | | Crystal Structure Matriptase (C731S) in Complex with Inhibitor VD4162B | | 分子名称: | CHLORIDE ION, Cyclic peptide inhibitor (ACE)Y(DTR)(NLE)(KCM), Cyclic peptide inhibitor (ACE)Y(DTR)(NLE)(THZ), ... | | 著者 | Lovell, S, Kashipathy, M.M, Battaile, K.P, Janetka, J.W. | | 登録日 | 2023-02-03 | | 公開日 | 2024-02-07 | | 最終更新日 | 2024-04-10 | | 実験手法 | X-RAY DIFFRACTION (1.2 Å) | | 主引用文献 | Mechanism-Based Macrocyclic Inhibitors of Serine Proteases.
J.Med.Chem., 67, 2024
|
|
8USM
 | | FmlH Lectin Domain UTI89 - AM4085 | | 分子名称: | 4'-fluoro-6-(trifluoromethyl)[1,1'-biphenyl]-2-yl 2-acetamido-2-deoxy-beta-D-galactopyranoside, Fimbrial protein (Fragment) | | 著者 | Tamadonfar, K.O, Pinkner, J.P, Maddirala, A.R, Janetka, J.W, Hultgren, S.J. | | 登録日 | 2023-10-27 | | 公開日 | 2024-02-14 | | 最終更新日 | 2024-03-27 | | 実験手法 | X-RAY DIFFRACTION (1.63 Å) | | 主引用文献 | Discovery of Orally Bioavailable FmlH Lectin Antagonists as Treatment for Urinary Tract Infections.
J.Med.Chem., 67, 2024
|
|
